All entries for: Dewpoint Therapeutics Inc.

October 22, 2025

Dewpoint Therapeutics Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of gastric cancer, including gastroesophageal junction cancer

Disease Area: Rare Diseases
Scroll to Top